Minutes - TRIPS Council - View details of the intervention/statement

Ambassador Mothusi Palai (Botswana)
17.4 Extension of the transition period under Article 66.1 of the TRIPS Agreement for Least developed country Members for certain obligations with respect to pharmaceutical products
675. I would like to make a small statement on behalf of Bangladesh. Let me align ourselves with the statement made on behalf of the LDC Group. 676. Today's WHO presentation was very enlightening in helping us to further understand another dimension of socio-economic importance. In the same vein, we would also appreciate a WHO presentation on disease profile, prevalence and access to medicines from the perspective of public health, focusing particularly on LDCs. This presentation would help us to concentrate further to factual discussion in our future meetings.
The Council took note of the statements made.
17.8. The Chairman said that the delegation of Uganda, on behalf of the LDC Group, had indicated at the beginning of the meeting that it wished to make a statement under "Other Business" concerning "Extension of the transition period under Article 66.1 of the TRIPS Agreement for least developed country Members for certain obligations with respect to pharmaceutical products".

17.9. The representatives of Bangladesh, on behalf of the LDC Group and Bangladesh took the floor.

17.10. The Council took note of the statements made.

IP/C/M/77, IP/C/M/77/Add.1